| Product Name | CAS Registry Number | Molecular Formula |
|---|---|---|
| 5-(Morpholin-4-yl)pyridin-2-amine | 571189-78-1 | C9H13N3O |
| 6-(Morpholin-4-yl)pyridine-3-boronic acid pinacol ester | 485799-04-0 | C15H23BN2O3 |
| 6-(Morpholin-4-yl)pyridine-3-carbonitrile | 259683-28-8 | C10H11N3O |
| 6-(Morpholin-4-yl)pyridine-3-carboxaldehyde | 173282-60-5 | C10H12N2O2 |
| 6-(4-morpholinyl)-3-pyridinylboronic acid | 904326-93-8 | C9H13BN2O3 |
| 1-[6-(4-Morpholinyl)-3-pyridinyl]cyclopropanamine | 566161-18-0 | C12H17N3O |
| 3-[4-(4-Morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]benzenamine | 371934-59-7 | C19H17N5O2 |
| 3-[4-(4-Morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol monohydrochloride | 371935-79-4 | C19H16N4O3.HCl |
| 2-Morpholin-4-YL-pyrimidin-4-ylamine | 18215-94-6 | C8H12N4O |
| 2-(Morpholin-4-yl)pyrimido[2,1-a]isoquinolin-4-one | 168425-64-7 | C16H15N3O2 |
| (2b,3a,5a,16b,17b)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol | 119302-20-4 | C27H46N2O3 |
| 3-[4-(4-Morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile | 1527473-33-1 | C17H15N5O |
| 3-(4-Morpholinylsulfonyl)benzoic acid (2E)-2-[1-(5-chloro-2-hydroxyphenyl)ethylidene]hydrazide | 1423715-09-6 | C19H20ClN3O5S |
| 5-[4-(4-Morpholinylsulfonyl)phenyl]-2-furancarboxaldehyde | 327106-59-2 | C15H15NO5S |
| 2-(4-Morpholinyl)-4-(trifluoromethyl)-5-pyrimidinecarboxylic acid ethyl ester | 677706-89-7 | C12H14F3N3O3 |
| Morphotox | 144-41-2 | C8H16NO4PS2 |
| Morroniside | 25406-64-8 | C17H26O11 |
| Morusin | 62596-29-6 | C25H24O6 |
| Morusinol | 62949-93-3 | C25H26O7 |
| Mosapramine dihydrochloride | 98043-60-8 | C28H35ClN4O.2(HCl) |
| Mosapride | 112885-41-3 | C21H25ClFN3O3 |
| Mosapride citrate | 112885-42-4 | C21H25ClFN3O3.C6H8O7;C27H33ClFN3O10 |
| Mosapride citrate dihydrate | 156925-25-6 | C21H25ClFN3O3.C6H8O7.2(H2O) |
| Mosapride Citrate Dihydrate | 636582-62-2 | C27H37ClFN3O12 |
| cis-Moschamine | 193224-24-7 | C20H20N2O4 |
| Motavizumab | 677010-34-3 | |
| Motesanib | 453562-69-1 | C22H23N5O |
| Motesanib diphosphate | 857876-30-3 | C22H23N5O.2(H3PO4) |
| Motilin | 52906-92-0 | |
| Motilin (canine) | 85490-53-5 | C120H194N36O34 |
| Motixafortide | 664334-36-5 | C97H144FN33O19S2 |
| Motolimod | 926927-61-9 | C28H34N4O2 |
| MOTS-C | 1627580-64-6 | C101H152N28O22S2 |
| Mouse leptin(116-130) amide | 258276-95-8 | C64H109N19O24S |
| Moveltipril | 85856-54-8 | C19H30N2O5S |
| Moveltipril calcium | 85921-53-5 | 2(C19H29N2O5S).Ca |
| Moxaverine hydrochloride | 1163-37-7 | C20H21NO2.HCl |
| Moxidectin | 113507-06-5 | C37H53NO8 |
| Moxifloxacin | 151096-09-2 | C21H24FN3O4 |
| (4R,7R)-Moxifloxacin | 268545-13-7 | C21H24FN3O4 |
| Moxifloxacin Boron Complex Impurity | 139693-52-0 | C22H25BO7 |
| Moxifloxacin-d3 | 1092356-42-7 | C21H21D3FN3O4 |
| Moxifloxacin Decarboxy Analog | 1322062-57-6 | C20H24FN3O2 |
| Moxifloxacin EP Impurity D | 2252446-69-6 | C21H24FN3O4 .HCl |
| Moxifloxacin EP Impurity C HCl | 2252446-70-9 | C22H27ClFN3O4 |
| Moxifloxacin Ethyl Ester | 1403836-23-6 | C23H28FN3O4 |
| Moxifloxacin hydrochloride | 186826-86-8 | C21H24FN3O4.HCl |
| Moxifloxacin hydrochloride monohydrate | 192927-63-2 | C21H24FN3O4.HCl.H2O |
| Moxifloxacin Impurity 12 | 1395056-41-3 | C21H22FN3O5 |
| Moxifloxacin Impurity 16 | 1797982-51-4 | C16H16FNO5 |